BRIEF published on 10/02/2026 at 19:29, 1 month 6 days ago ABIONYX: Information on Capital and Voting Rights Euronext Paris Share Capital Voting Rights Shares ABIONYX
BRIEF published on 10/02/2026 at 19:29, 1 month 6 days ago ABIONYX : Informations sur le Capital et les Droits de Vote Euronext Paris Droits De Vote Capital Social Actions ABIONYX
PRESS RELEASE published on 10/02/2026 at 19:24, 1 month 6 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre total de droits de vote et d'actions en circulation. La société se positionne comme acteur clé dans les soins intensifs avec des biothérapies innovantes Droits De Vote Actions Biothérapies ABIONYX Pharma Soins Intensifs
PRESS RELEASE published on 10/02/2026 at 19:24, 1 month 6 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares forming the company's share capital in compliance with French regulations Shares French Regulations Biopharmaceutical Total Voting Rights ABIONYX Pharma
BRIEF published on 10/02/2026 at 07:05, 1 month 7 days ago ABIONYX Pharma Settles Bond Amortization with Share Issuance Share Issuance ABIONYX Pharma Cash Runway Fenja Capital Bonds Amortization
BRIEF published on 10/02/2026 at 07:05, 1 month 7 days ago ABIONYX Pharma règle l'amortissement de ses obligations par une émission d'actions Émission D'actions ABIONYX Pharma Fenja Capital Routine De Trésorerie Amortissement Des Obligations
PRESS RELEASE published on 10/02/2026 at 07:00, 1 month 7 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce un amortissement anticipé partiel de son Financement Obligataire, réservé à Fenja Capital II A/S, avec émission d'Actions Nouvelles Actions Nouvelles Financement Obligataire ABIONYX Pharma Amortissement Anticipé Fenja
PRESS RELEASE published on 10/02/2026 at 07:00, 1 month 7 days ago Inside Information / Other news releases ABIONYX Pharma settles anticipated amortization payment under bonds financing agreement, issuing new ordinary shares to Fenja Capital and maintaining unchanged projected cash runway into Q4 2028 ABIONYX Pharma Cash Runway New Ordinary Shares Bonds Financing Amortization Payment
BRIEF published on 09/23/2026 at 21:41, 1 month 15 days ago ABIONYX Pharma Reports Half-Year Results for 2026 Financial Results Biopharmaceuticals Revenue Report LCAT Deficiency Sepsis Research
BRIEF published on 09/23/2026 at 21:41, 1 month 15 days ago ABIONYX Pharma publie ses résultats semestriels pour 2026 Résultats Financiers Produits Biopharmaceutiques Rapport Sur Les Revenus Recherche Sur La Septicémie Déficit En LCAT
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:30, 30 minutes ago Hannover Re increases Group profit and confirms full-year guidance
Published on 11/09/2026 at 07:30, 30 minutes ago SUSS Expands Photomask Portfolio with Next-Generation ASC9500 Mid-End Cleaner
Published on 11/09/2026 at 07:30, 30 minutes ago GEA delivers strong third quarter: order intake rises substantially, revenue and profitability further improved
Published on 11/09/2026 at 07:30, 30 minutes ago Nordex Group to enter Albania with 84 MW order from Verbund
Published on 11/09/2026 at 07:30, 30 minutes ago q.beyond posts high volume of one-off charges in Q3 2026 – restructuring set to pay off from 2027 onwards
Published on 11/09/2026 at 07:00, 1 hour 1 minute ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 1 minute ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 1 minute ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 1 minute ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
